, , , e.a.

Biosimilar Drug Product Development

Gebonden Engels 2017 9781498718790
€ 303,26
Levertijd ± 8 werkdagen
Gratis verzonden

Samenvatting

When a biological drug patent expires, alternative biosimilar products are developed. The development of biosimilar products is complicated and involves numerous considerations and steps. The assessment of biosimilarity and interchangeability is also complicated and difficult. Biosimilar Drug Product Development presents current issues for the development of biosimilars and gives detailed reviews of its various stages and contributing factors as well as relevant regulatory pathways and pre- and post-approval issues.

Lezersrecensies

Wees de eerste die een lezersrecensie schrijft!

Inhoudsopgave

Analytical characterization. Immunogenicity. Animal studies. Clinical development. Manufacturing, process control. Extrapolation of indications. Interchangeability, substitution. Pharmacovigilance. Statistical issues. Regulatory issues.

Managementboek Top 100

€ 303,26
Levertijd ongeveer 8 werkdagen
Gratis verzonden

Rubrieken

Producten

    Auteurs

      Trefwoorden

        Artikelen

          Biosimilar Drug Product Development